Nova Lifestyle (NASDAQ:NVFY) reported $3.60 million in sales this quarter. This is a 56.86 percent increase over sales of $2.29 million the same period last year.
UK’s Medicines And Healthcare Products Regulatory Agency Approves XEVUDY, GlaxoSmithKline And Vir Biotechnology’s Monoclonal Antibody Treatment For Patients With COVID-19
Brand Institute is proud to announce its successful partnership with GlaxoSmithKline and Vir Biotechnology in developing the brand name XEVUDY®, a monoclonal antibody therapeutic approved for symptomatic
